Annual Current Liabilities
$38.37 M
+$28.36 M+283.31%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual total current liabilities is $38.37 million, with the most recent change of +$28.36 million (+283.31%) on December 31, 2023.
- During the last 3 years, VIRX annual current liabilities has risen by +$32.09 million (+510.65%).
- VIRX annual current liabilities is now at all-time high.
Performance
VIRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$28.57 M
-$76.00 K-0.27%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly total current liabilities is $28.57 million, with the most recent change of -$76.00 thousand (-0.27%) on September 30, 2024.
- Over the past year, VIRX quarterly current liabilities has dropped by -$9.80 million (-25.53%).
- VIRX quarterly current liabilities is now -25.53% below its all-time high of $38.37 million, reached on December 31, 2023.
Performance
VIRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VIRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +283.3% | -25.5% |
| 3 y3 years | +510.6% | -25.5% |
| 5 y5 years | +510.6% | -25.5% |
VIRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +322.4% | -25.5% | +295.7% |
| 5 y | 5-year | at high | +510.6% | -25.5% | +356.1% |
| alltime | all time | at high | +510.6% | -25.5% | +356.1% |
Viracta Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.57 M(-0.3%) |
| Jun 2024 | - | $28.65 M(-5.3%) |
| Mar 2024 | - | $30.25 M(-21.2%) |
| Dec 2023 | $38.37 M(+283.3%) | $38.37 M(+5.3%) |
| Sep 2023 | - | $36.43 M(+139.5%) |
| Jun 2023 | - | $15.21 M(+30.5%) |
| Mar 2023 | - | $11.65 M(+16.4%) |
| Dec 2022 | $10.01 M | $10.01 M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $9.39 M(+30.0%) |
| Jun 2022 | - | $7.22 M(-7.0%) |
| Mar 2022 | - | $7.77 M(-14.5%) |
| Dec 2021 | $9.08 M(+44.6%) | $9.08 M(+26.9%) |
| Sep 2021 | - | $7.16 M(+3.0%) |
| Jun 2021 | - | $6.95 M(+11.0%) |
| Mar 2021 | - | $6.26 M(-0.3%) |
| Dec 2020 | $6.28 M | $6.28 M |
FAQ
- What is Viracta Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics annual current liabilities year-on-year change?
- What is Viracta Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly current liabilities year-on-year change?
What is Viracta Therapeutics annual total current liabilities?
The current annual current liabilities of VIRX is $38.37 M
What is the all time high annual current liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high annual total current liabilities is $38.37 M
What is Viracta Therapeutics annual current liabilities year-on-year change?
Over the past year, VIRX annual total current liabilities has changed by +$28.36 M (+283.31%)
What is Viracta Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VIRX is $28.57 M
What is the all time high quarterly current liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly total current liabilities is $38.37 M
What is Viracta Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VIRX quarterly total current liabilities has changed by -$9.80 M (-25.53%)